Machine learning on drug-specific data to predict small molecule teratogenicity.

Chemical structure Drug development Drug exposure High-throughput screening Informatics Machine learning Teratogenicity Translational medicine

Journal

Reproductive toxicology (Elmsford, N.Y.)
ISSN: 1873-1708
Titre abrégé: Reprod Toxicol
Pays: United States
ID NLM: 8803591

Informations de publication

Date de publication:
08 2020
Historique:
received: 05 12 2019
revised: 04 05 2020
accepted: 06 05 2020
pubmed: 20 5 2020
medline: 29 4 2021
entrez: 20 5 2020
Statut: ppublish

Résumé

Pregnant women are an especially vulnerable population, given the sensitivity of a developing fetus to chemical exposures. However, prescribing behavior for the gravid patient is guided on limited human data and conflicting cases of adverse outcomes due to the exclusion of pregnant populations from randomized, controlled trials. These factors increase risk for adverse drug outcomes and reduce quality of care for pregnant populations. Herein, we propose the application of artificial intelligence to systematically predict the teratogenicity of a prescriptible small molecule from information inherent to the drug. Using unsupervised and supervised machine learning, our model probes all small molecules with known structure and teratogenicity data published in research-amenable formats to identify patterns among structural, meta-structural, and in vitro bioactivity data for each drug and its teratogenicity score. With this workflow, we discovered three chemical functionalities that predispose a drug towards increased teratogenicity and two moieties with potentially protective effects. Our models predict three clinically-relevant classes of teratogenicity with AUC = 0.8 and nearly double the predictive accuracy of a blind control for the same task, suggesting successful modeling. We also present extensive barriers to translational research that restrict data-driven studies in pregnancy and therapeutically "orphan" pregnant populations. Collectively, this work represents a first-in-kind platform for the application of computing to study and predict teratogenicity.

Identifiants

pubmed: 32428651
pii: S0890-6238(20)30132-5
doi: 10.1016/j.reprotox.2020.05.004
pmc: PMC7577422
mid: NIHMS1637386
pii:
doi:

Substances chimiques

Teratogens 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

148-158

Subventions

Organisme : NHLBI NIH HHS
ID : K01 HL141771
Pays : United States
Organisme : NHGRI NIH HHS
ID : U54 HG007963
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002243
Pays : United States

Informations de copyright

Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

Birth Defects Res C Embryo Today. 2015 Jun;105(2):140-56
pubmed: 26043938
Nat Commun. 2015 Feb 05;6:6220
pubmed: 25653139
Ann Transl Med. 2019 Apr;7(7):152
pubmed: 31157273
Pharmacoepidemiol Drug Saf. 2018 Dec;27(12):1309-1315
pubmed: 30240072
Rheum Dis Clin North Am. 2017 Aug;43(3):489-502
pubmed: 28711148
Hum Reprod Update. 2016 Mar-Apr;22(2):240-59
pubmed: 26590298
Toxicol Sci. 2011 Jul;122(1):1-6
pubmed: 21507989
Sci Rep. 2015 Nov 03;5:15951
pubmed: 26526519
Annu Rev Biophys Biomol Struct. 2004;33:119-40
pubmed: 15139807
Clujul Med. 2016;89(4):513-518
pubmed: 27857521
Toxicol Appl Pharmacol. 1995 Mar;131(1):1-12
pubmed: 7878664
Curr Protoc Pharmacol. 2010 Jun;Chapter 9:Unit 9.12
pubmed: 22294375
Reprod Toxicol. 2019 Apr;85:65-74
pubmed: 30738954
Birth Defects Res A Clin Mol Teratol. 2016 Nov;106(11):927-934
pubmed: 27891779
Bioinformatics. 2008 Aug 1;24(15):1733-4
pubmed: 18596077
Comput Math Methods Med. 2018 Nov 4;2018:8019232
pubmed: 30532798
Lancet Oncol. 2019 May;20(5):e262-e273
pubmed: 31044724
Sci Rep. 2017 Oct 9;7(1):12839
pubmed: 28993650
Science. 1979 May 11;204(4393):587-93
pubmed: 373122
Arch Ophthalmol. 1971 Jan;85(1):1-2
pubmed: 5099659
Drug Discov Today. 2018 Aug;23(8):1538-1546
pubmed: 29750902
Am J Reprod Immunol. 2018 Aug;80(2):e12971
pubmed: 29726581
Bioinformatics. 2018 Sep 1;34(17):2988-2996
pubmed: 29912272
Sci Rep. 2016 Jul 22;6:30038
pubmed: 27443489
Trials. 2018 Jan 29;19(1):78
pubmed: 29378652
Pediatr Res. 1998 Jan;43(1):1-7
pubmed: 9432105
Am J Obstet Gynecol. 2001 May;184(6):1289-96
pubmed: 11349204
J Anim Sci Biotechnol. 2018 Jan 30;9:18
pubmed: 29423216
Annu Rev Pharmacol Toxicol. 2020 Jan 6;60:333-352
pubmed: 31337270
Cell Biosci. 2012 Mar 22;2(1):11
pubmed: 22439772
PLoS One. 2013 Sep 20;8(9):e75252
pubmed: 24073257
J Med Internet Res. 2019 Mar 25;21(3):e12422
pubmed: 30907742
PLoS One. 2013;8(2):e56883
pubmed: 23457633
Front Pharmacol. 2019 Jan 29;10:31
pubmed: 30761002
J Cheminform. 2016 Oct 31;8:60
pubmed: 27853484
Biol Reprod. 2019 Apr 1;100(4):1073-1081
pubmed: 30418498
Birth Defects Res. 2020 Jan 1;112(1):19-39
pubmed: 31471948
Gen Comp Endocrinol. 2010 Apr 1;166(2):307-13
pubmed: 19854190
BMC Bioinformatics. 2011 Mar 17;12:77
pubmed: 21414208
JAMA. 1974 Nov 18;230(7):1019-20
pubmed: 4479553
Nat Rev Drug Discov. 2019 Oct;18(11):826
pubmed: 31673126
Toxicol Pathol. 2013 Feb;41(2):310-4
pubmed: 23085982
J Med Chem. 2013 Sep 12;56(17):6560-72
pubmed: 23688234
Adv Pharmacol Sci. 2014;2014:924706
pubmed: 24639869
ORL Head Neck Nurs. 2007;25(4):15
pubmed: 18728734
Brief Bioinform. 2018 Nov 27;19(6):1236-1246
pubmed: 28481991
J Clin Lipidol. 2016 Sep-Oct;10(5):1081-90
pubmed: 27678424
Pharmacol Res. 2018 Apr;130:44-51
pubmed: 29448118
Birth Defects Res. 2019 Oct 1;111(16):1145-1153
pubmed: 31433567
BMC Bioinformatics. 2018 Jul 17;19(1):270
pubmed: 30016950
Toxicol Res (Camb). 2018 Nov 29;8(2):157-171
pubmed: 30997019
Arch Gynecol Obstet. 2011 Jan;283(1):7-18
pubmed: 20814687
Clin Pharmacol Ther. 1964 Jul-Aug;5:480-514
pubmed: 14203841
BMC Syst Biol. 2018 Nov 22;12(Suppl 6):105
pubmed: 30463545
Hum Reprod Update. 2010 Jul-Aug;16(4):378-94
pubmed: 20061329
Diabetes Care. 2016 Jun;39(6):1004-9
pubmed: 27208329
Nat Commun. 2016 Jan 26;7:10425
pubmed: 26811972
Eur J Obstet Gynecol Reprod Biol. 2009 Apr;143(2):75-8
pubmed: 19181435
J Chem Inf Model. 2010 May 24;50(5):822-39
pubmed: 20423098
Neural Plast. 2015;2015:170435
pubmed: 26413323
Nucleic Acids Res. 2018 Jan 4;46(D1):D1074-D1082
pubmed: 29126136
Mayo Clin Proc. 1991 Dec;66(12):1249-59
pubmed: 1749294
J Hypertens. 2017 Nov;35(11):2123-2137
pubmed: 28661961
P T. 2016 Nov;41(11):713-715
pubmed: 27904304
Reprod Toxicol. 2011 May;31(4):562-9
pubmed: 21115113
Proc (Bayl Univ Med Cent). 2003 Jul;16(3):354-8
pubmed: 16278712

Auteurs

Anup P Challa (AP)

Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville 37203, TN, United States; Department of Biomedical Informatics, Harvard Medical School, Boston 02115, MA, United States; National Center for Advancing Translational Sciences, National Institutes of Health, Rockville 20850, MD, United States; Department of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville 37212, TN, United States. Electronic address: anup.p.challa.1@vumc.org.

Andrew L Beam (AL)

Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston 02115, MA, United States; Department of Biomedical Informatics, Harvard Medical School, Boston 02115, MA, United States.

Min Shen (M)

National Center for Advancing Translational Sciences, National Institutes of Health, Rockville 20850, MD, United States.

Tyler Peryea (T)

National Center for Advancing Translational Sciences, National Institutes of Health, Rockville 20850, MD, United States.

Robert R Lavieri (RR)

Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville 37203, TN, United States.

Ethan S Lippmann (ES)

Department of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville 37212, TN, United States.

David M Aronoff (DM)

Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville 37203, TN, United States; Department of Obstetrics and Gynecology, Vanderbilt University Medical Center, Nashville 37203, TN, United States; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville 37203, TN, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH